15.39 stock price down
Change
- 0.11 (0.71%)
Volume
400
Exchange
NASDAQ
As of 10:05 AM ET on Jan 30, 2015
Delayed at least 20 minutes.
Provided by eSignal.
6.06 stock price down
Change
- 0.01 (0.08%)
Volume
184,307
Exchange
TASE
As of 3:24 PM Israel Time on Jan 29, 2015
Delayed at least 20 minutes.
Provided by eSignal.
View all »Recent Releases

Jan 29, 2015
RedHill Biopharma Provides Update on Progress With RHB-104 Ongoing Phase III Program for Crohn's Disease Following FDA Meeting

Jan 28, 2015
RedHill Biopharma to Present at the 17th Annual BIO CEO & Investor Conference

Jan 9, 2015
RedHill Biopharma to Present at Biotech Showcase(TM) 2015 Conference in San Francisco

View all »Upcoming Events & Presentations

Feb 9, 2015 - Feb 10, 2015
BIO CEO & Investors conference
The Waldorf Astoria New York

Feb 18, 2015 - Feb 19, 2015
Life Sciences Israel 2015
Dan Panorama, Tel-Aviv

Mar 9, 2015 - Mar 11, 2015
Bio Europe Spring 2015
Paris Expo - Porte de Versailles

Investor Relations (US):

Lauren Glaser
Vice President
The Trout Group LLC
Direct: +1 646 378 2972
Cell: +1 215 740 8468
email: lglaser@troutgroup.com

Investor Relations (Israel):

Eran Gabay
Vice President & Managing Director
Financial PR and Strategic Communications
Gelbart-Kahana Investor Relations
Direct: +972 (0)3 6070 591
email: erang@gk-biz.com

General:

RedHill Biopharma Ltd.
21 Ha’arba’a St., Tel-Aviv 64739, Israel
Tel: +972 (0)3 541 3131
Fax: +972 (0)3 541 3144
email: info@redhillbio.com